(NASDAQ)
8.55
-0.93   (-9.81%)
After Hours: 8.29 -0.26 (-3.04%)
Volume (24h) Market Cap. Day Range 52w Range
27.74M 2.32B 8.45 - 9.59 0.26 - 15.69
Mar-03-21 09:07AM Bionano Customer Praxis Genomics Receives DEX Z-Codes from Palmetto for their Whole Genome Analysis LDT on SaphyrGlobeNewswire
Mar-02-21 08:22AM Bionano Genomics to Present at the Cowen 41st Annual Health Care ConferenceGlobeNewswire
Mar-01-21 05:45AM Bionano Genomics, Inc. (BNGO) Gains But Lags Market: What You Should KnowZacks
08:00AM Bionano to be Featured at AGBT 2021 with Presentations of Scientific Discoveries made with Saphyr in Psychiatric Disorders and CancerGlobeNewswire
Feb-25-21 04:30AM Bionano’s Saphyr Data Prove Essential in Creating the Most Comprehensive, Ethnically Diverse Collection of Genome Variation Ever CompletedGlobeNewswire
04:27AM Analyst Pounds the Table on Bionano (BNGO) StockTipRanks
Feb-23-21 09:41AM Analyzing Bionano Genomics's Unusual Options ActivityBenzinga
Feb-22-21 11:50AM Did The Underlying Business Drive Bionano Genomics' (NASDAQ:BNGO) Lovely 997% Share Price Gain?Simply Wall St.
08:00AM Bionano Publishes Method for Identifying Genes Likely to Cause Neurological Diseases Based on a Model Developed by Lineagen to Improve Interpretation of Variants of Unknown SignificanceGlobeNewswire
Feb-22-21 06:05AM Is It Too Late to Buy Bionano Genomics Stock?Motley Fool
Feb-16-21 03:43AM Best Stocks in the Past Week: Riot Blockchain, MicrostrategyTheStreet.com
Feb-15-21 03:00AM Best Stocks in the Past Week: Bionano Genomics SurgesTheStreet.com
Feb-13-21 07:25AM Is BioNano Genomics Stock a Buy?Motley Fool
Feb-12-21 07:38AM Why Bionano Genomics Stock Surged TodayMotley Fool
05:28AM 4 Top Stock Trades for Tuesday: MJ, NWL, CIIC, BNGOInvestorPlace
Feb-11-21 04:42AM Bionano Genomics to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewswire
08:00AM Method for Solid Tumor Analysis with Saphyr Published by Penn State Institute for Personalized Medicine, Opening Largest Oncology Market to Optical Genome MappingGlobeNewswire
Feb-10-21 04:31AM Should Investors Think Twice Before Running After BioNano Genomics?TipRanks
Feb-09-21 05:45AM Bionano Genomics, Inc. (BNGO) Gains As Market Dips: What You Should KnowZacks
08:00AM Largest Hospital Diagnostic Lab in Canada Pilots Bionano’s Saphyr; Seeking to Convert 30-Year-Old Workflow Based on Multiple Technologies Into a Single, High-Resolution Assay to Transform Cancer DiagnosisGlobeNewswire
Feb-08-21 01:34AM Bionano Stock Gets a New Street-High Price TargetTipRanks
Feb-06-21 06:35AM 3 Stocks That Turned $200,000 Into $1 Million (or More) in 3 MonthsMotley Fool
Feb-05-21 08:00AM Presentation Recordings from Bionano’s Next-Generation Cytogenomics Symposium, its Most Attended Event to Date, Now Available OnlineGlobeNewswire
Feb-03-21 05:45AM Bionano Genomics, Inc. (BNGO) Stock Sinks As Market Gains: What You Should KnowZacks
Feb-02-21 10:46AM ROCE Insights For Bionano GenomicsBenzinga
08:00AM Saphyr Study Is First to Analyze Cancer Regulation at Level of Single DNA Molecules, Opens Promising New Avenue of Cancer ResearchGlobeNewswire
Jan-29-21 08:00AM Dr. Gordana Raca from Children’s Hospital Los Angeles Presents Findings That Show Saphyr Detects Druggable Gene Fusions in Pediatric Acute Leukemias that NGS and Cytogenetics MissedGlobeNewswire
Jan-27-21 08:00AM Bionano Chief Medical Officer Presents Vision for Optical Genome Mapping as a First Line Clinical Tool for Cancer and Genetic Disease Testing at Festival of Genomics & BiodataGlobeNewswire
06:10AM Should You Buy Bionano Genomics Stock?Motley Fool
Jan-26-21 08:00AM Bionano Significantly Reduces Analysis Cost and Time to Actionable Results with Update to its Cloud ComputeGlobeNewswire
06:06AM 3 Electric Stocks That Turned $100,000 Into $1 Million in 6 MonthsMotley Fool
Jan-25-21 04:19AM Why Bionano Genomics Stock Rocketed More Than 28% TodayMotley Fool
02:23AM Is Bionano Stock Still Worth Buying After Its 2,300%-Plus Rally? Analyst Weighs InTipRanks
Jan-25-21 08:00AM Bionano Genomics Announces Closing of $230 Million Underwritten Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobeNewswire
Jan-22-21 01:42AM Why Bionano Genomics Stock Popped TodayMotley Fool
01:15AM Why Bionano Has Tremendous PotentialInvestorPlace
Jan-22-21 09:47AM Bionano Genomics' stock rally result of awareness push in 2019 and 2020 about its genomic technology: analystMarketWatch
08:34AM Maxim Group: Bionano's stock rally result of awareness push in 2019 and 2020 about its genomic technologyMarketWatch
Jan-20-21 07:59AM UPDATE: Bionano Genomics prices $200 million underwritten stock offering at a discount of $6 a shareMarketWatch
07:45AM Bionano Genomics Announces Pricing of $200 Million Underwritten Public Offering of Common StockGlobeNewswire
Jan-19-21 05:28AM Bionano Genomics to sell more shares, stock fallsMarketWatch
04:25AM Bionano Genomics Announces Proposed Underwritten Public Offering of Common StockGlobeNewswire
Jan-19-21 08:00AM MD Anderson Cancer Center Publication Shows How Bionano’s Saphyr System Can Significantly Reduce Time to Actionable Results for Myelodysplastic Syndrome PatientsGlobeNewswire
Jan-18-21 07:00AM Day Five of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Identifies Structural Variants that May Predispose to Severe COVID-19 IllnessGlobeNewswire
Jan-15-21 08:00AM Day Four of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Solves Genetic Mysteries, Enables Study of Complex Genetic Diseases, Simplifies Muscular Dystrophy TestingGlobeNewswire
Jan-14-21 08:00AM Day Three of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Provides Complete Structural Variation Analysis in Solid Tumors, Enables Discovery of Novel Diagnostic Markers and Drug TargetsGlobeNewswire
Jan-13-21 04:01AM Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing RequirementGlobeNewswire
08:00AM Day Two of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Outperforms Standard Cytogenetics in Heme Malignancies, is Less Expensive, Provides Actionable Information Faster, in Single AssayGlobeNewswire
Jan-12-21 05:04AM Bionano Genomics Announces Closing of $101.8 Million Underwritten Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobeNewswire
09:00AM Day One of Bionano’s Next-Generation Cytogenomics Symposium: Customer Progress in Applications Development in Prenatal Testing, Validation Against Traditional Cytogenetics and Resolution for Undiagnosed PatientsGlobeNewswire
Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Its Saphyr system comprises an instrument, chip consumables, reagents, and a suite of data analysis tools. The company's Bionano prep kits and labeling kits provide the critical reagents and protocols needed to extract and label high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. It sells its instruments and consumables for research use applications primarily to laboratories associated with academic and governmental research institutions, as well as to pharmaceutical, biotechnology, and contract research companies in North America, Europe, the Middle East, India, Africa, and the Asia Pacific. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
Cap:    |  Volume (24h):